Acute Renal Infarction Due to Symptomatic Isolated Spontaneous Renal Artery Dissection: A Rare and Fatal Disease.

IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE
Journal of Endovascular Therapy Pub Date : 2025-02-01 Epub Date: 2023-05-08 DOI:10.1177/15266028231168352
Yangyan He, Yujian Hu, Lu Tian, Chenyang Qiu, Donglin Li, Yilang Xiang, Xiaohui Wang, Yunjun He, Xun Wang, Tao Shang, Qianqian Zhu, Tianchi Chen, Zhenjiang Li, Qinglong Zeng, Ziheng Wu, Hongkun Zhang
{"title":"Acute Renal Infarction Due to Symptomatic Isolated Spontaneous Renal Artery Dissection: A Rare and Fatal Disease.","authors":"Yangyan He, Yujian Hu, Lu Tian, Chenyang Qiu, Donglin Li, Yilang Xiang, Xiaohui Wang, Yunjun He, Xun Wang, Tao Shang, Qianqian Zhu, Tianchi Chen, Zhenjiang Li, Qinglong Zeng, Ziheng Wu, Hongkun Zhang","doi":"10.1177/15266028231168352","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To report demographics and clinical, laboratory, and imaging features of acute renal infarction (ARI) due to symptomatic isolated spontaneous renal artery dissection (SISRAD) and to analyze outcomes after the initial therapy for SISRAD.</p><p><strong>Methods: </strong>Thirteen patients with ARI due to SISRAD between January 2016 and March 2021 were enrolled in this retrospective study. We reviewed the demographics, clinical, laboratory, and imaging features (location of the infarct kidney, the branch artery involved by dissection, true lumen stenosis, false lumen thrombosis, and aneurysm), treatment modalities, and follow-up results; analyzed the difference between SISRAD and other causes of ARI; and propose an appropriate therapy strategy for SISRAD based on our data and literature.</p><p><strong>Result: </strong>Patients with ARI due to SISRAD were mostly young men (43 [24-53] years; 12/13 [92%]). No patients had atrial fibrillation or acute kidney injury at admission (0/13). All 13 patients received conservative treatment as the initial treatment. Sixty-two percent (8/13) of patients progressed, and 88% (7/8) of them had dissection aneurysm on the admission computed tomographic angiography (CTA) image. Seventy-five percent (6/8) of patients underwent endovascular intervention as follows, stent placement in 1 patient, renal artery embolization in 1, and stent placement with embolization in 4. Two patients with disease progression died: 1 during the conservative treatment period and 1 after the stent placement. Thirty-eight percent (5/13) of patients in remission continued to receive conservative treatment, none of whom had dissection aneurysm on the admission CTA.</p><p><strong>Conclusion: </strong>Symptomatic isolated spontaneous renal artery dissection is a rare and fatal disease. For young ARI patients with no previous history of tumors and cardiogenic diseases, CTA examination is recommended to exclude SISRAD. Dissection aneurysm seems to be a risk of progression for SISRAD in this series. Conservative treatment, a recognized initial treatment, has a good effect on patients without dissection aneurysm, and we recommend endovascular intervention as the initial treatment for the patient with dissection aneurysm at admission. Multicenter clinical studies are needed to explore a more-appropriate treatment for patients with SISRAD.</p><p><strong>Clinical impact: </strong>This article report the related factors, risks, demographics and laboratory data of Acute renal infarction (ARI) due to Symptomatic isolated spontaneous renal artery dissection (SISRAD) and explore a better initial therapy strategy for SISRAD. It will help improve the effectiveness of SISRAD treatment and reduce the mortality rate from this rare but lethal disease.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"130-138"},"PeriodicalIF":1.7000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endovascular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15266028231168352","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/5/8 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To report demographics and clinical, laboratory, and imaging features of acute renal infarction (ARI) due to symptomatic isolated spontaneous renal artery dissection (SISRAD) and to analyze outcomes after the initial therapy for SISRAD.

Methods: Thirteen patients with ARI due to SISRAD between January 2016 and March 2021 were enrolled in this retrospective study. We reviewed the demographics, clinical, laboratory, and imaging features (location of the infarct kidney, the branch artery involved by dissection, true lumen stenosis, false lumen thrombosis, and aneurysm), treatment modalities, and follow-up results; analyzed the difference between SISRAD and other causes of ARI; and propose an appropriate therapy strategy for SISRAD based on our data and literature.

Result: Patients with ARI due to SISRAD were mostly young men (43 [24-53] years; 12/13 [92%]). No patients had atrial fibrillation or acute kidney injury at admission (0/13). All 13 patients received conservative treatment as the initial treatment. Sixty-two percent (8/13) of patients progressed, and 88% (7/8) of them had dissection aneurysm on the admission computed tomographic angiography (CTA) image. Seventy-five percent (6/8) of patients underwent endovascular intervention as follows, stent placement in 1 patient, renal artery embolization in 1, and stent placement with embolization in 4. Two patients with disease progression died: 1 during the conservative treatment period and 1 after the stent placement. Thirty-eight percent (5/13) of patients in remission continued to receive conservative treatment, none of whom had dissection aneurysm on the admission CTA.

Conclusion: Symptomatic isolated spontaneous renal artery dissection is a rare and fatal disease. For young ARI patients with no previous history of tumors and cardiogenic diseases, CTA examination is recommended to exclude SISRAD. Dissection aneurysm seems to be a risk of progression for SISRAD in this series. Conservative treatment, a recognized initial treatment, has a good effect on patients without dissection aneurysm, and we recommend endovascular intervention as the initial treatment for the patient with dissection aneurysm at admission. Multicenter clinical studies are needed to explore a more-appropriate treatment for patients with SISRAD.

Clinical impact: This article report the related factors, risks, demographics and laboratory data of Acute renal infarction (ARI) due to Symptomatic isolated spontaneous renal artery dissection (SISRAD) and explore a better initial therapy strategy for SISRAD. It will help improve the effectiveness of SISRAD treatment and reduce the mortality rate from this rare but lethal disease.

自发性孤立性肾动脉夹层引起的急性肾梗死:一种罕见且致命的疾病。
目的:报道由症状性孤立性自发性肾动脉夹层(SISRAD)引起的急性肾梗死(ARI)的人口学特征、临床、实验室和影像学特征,并分析SISRAD初始治疗后的结果。方法:2016年1月至2021年3月期间,13例因SISRAD导致ARI的患者被纳入这项回顾性研究。我们回顾了患者的人口统计学、临床、实验室和影像学特征(梗死肾的位置、被夹层累及的分支动脉、真管腔狭窄、假管腔血栓和动脉瘤)、治疗方式和随访结果;分析了SISRAD与ARI其他病因的差异;并根据我们的数据和文献提出适合SISRAD的治疗策略。结果:SISRAD致ARI患者以年轻男性居多(43[24-53]岁;12/13[92%])。入院时无患者房颤或急性肾损伤(0/13)。13例患者均采用保守治疗作为初始治疗。62%(8/13)的患者进展,88%(7/8)的患者在入院时的ct血管造影(CTA)图像上有夹层动脉瘤。75%(6/8)的患者接受了以下血管内介入治疗:1例置入支架,1例肾动脉栓塞,4例置入支架并栓塞。2例疾病进展死亡:1例在保守治疗期间死亡,1例在支架置入后死亡。38%(5/13)缓解的患者继续接受保守治疗,入院时没有一例动脉瘤夹层。结论:有症状孤立性自发性肾动脉夹层是一种罕见且致命的疾病。对于既往无肿瘤及心源性疾病史的年轻ARI患者,建议CTA检查排除SISRAD。在这个系列中,动脉瘤夹层似乎是SISRAD进展的风险。保守治疗是一种公认的初始治疗方法,对于无夹层动脉瘤的患者效果良好,我们建议在入院时对夹层动脉瘤患者进行血管内介入治疗。需要多中心临床研究来探索更适合SISRAD患者的治疗方法。临床影响:本文报道了症状性孤立性自发性肾动脉夹层(SISRAD)致急性肾梗死(ARI)的相关因素、风险、人口学和实验室数据,并探讨了更好的SISRAD初始治疗策略。这将有助于提高SISRAD治疗的有效性,并降低这种罕见但致命的疾病的死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
15.40%
发文量
203
审稿时长
6-12 weeks
期刊介绍: The Journal of Endovascular Therapy (formerly the Journal of Endovascular Surgery) was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology. An official publication of the International Society of Endovascular Specialists (ISEVS), the Journal of Endovascular Therapy publishes peer-reviewed articles of interest to clinicians and researchers in the field of peripheral endovascular interventions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信